This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Pep-Therapy. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Leticia Dominguez Berrocal: Innovator in Cell Penetrating Peptides
Introduction
Leticia Dominguez Berrocal is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of cell penetrating peptides. Her innovative work has led to the creation of a patented method for delivering cargo molecules into cells, which has important implications for medical research and treatment.
Latest Patents
Leticia holds a patent for "Cell penetrating peptides with improved internalization properties." This patent describes a method that links a cargo molecule to a cell penetrating peptide, enhancing the delivery of therapeutic agents into cells. The invention also includes chimeric constructs that comprise cell penetrating moieties, showcasing her innovative approach to solving complex biological challenges.
Career Highlights
Throughout her career, Leticia has worked with esteemed institutions such as Sorbonne Université and the Institut National de la Santé et de la Recherche Médicale. Her experience in these prestigious organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Leticia has collaborated with notable colleagues, including Angelita Rebollo and Jesus Maria Fominaya Gutierrez. These partnerships have further enriched her research and expanded the impact of her innovations in biotechnology.
Conclusion
Leticia Dominguez Berrocal is a trailblazer in the field of cell penetrating peptides, with a patented method that enhances the delivery of therapeutic agents into cells. Her work continues to influence the landscape of medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile